Patents by Inventor Gaiane Demirdjian

Gaiane Demirdjian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method diagnosis of a prenatal disorder by selective determination of placental growth factor 2
    Patent number: 11307209
    Abstract: The present invention relates to an immunoassay method for placental growth factor 2 (PlGF-2) detection in pregnant subjects. Furthermore the invention relates to the use of said method for the diagnosis, prognosis, risk assessment and therapy control of prenatal disorders comprising the determination of the level of PlGF-2 in said pregnant subjects.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: April 19, 2022
    Assignee: CÉZANNE S.A.S.
    Inventors: Gaïané Demirdjian, Delphine Espinasse
  • EARLY PLACENTA INSULIN-LIKE PEPTIDE (PRO-EPIL)
    Publication number: 20170122959
    Abstract: The present invention relates to a method for the diagnosis, prognosis, risk assessment, risk stratification and/or therapy control of a prenatal disorder or condition in a pregnant female subject or the unborn fetus of said subject comprising the steps of: i) providing a sample of a bodily fluid of said subject; ii) determining the level of early placenta insulin-like peptide (pro-EPIL) or a fragment thereof in said sample; iii) comparing the determined level in the sample to a control level derived from subjects without said prenatal disorder or condition; wherein a deviation from said control level is indicative for said prenatal disorder or condition in said subject.
    Type: Application
    Filed: May 18, 2015
    Publication date: May 4, 2017
    Inventors: Gaïané DEMIRDJIAN, Delphine ESPINASSE, Nicolas BOURGOIN
  • METHOD FOR THE SELECTIVE DETERMINATION OF PLACENTAL GROWTH FACTOR 2
    Publication number: 20170003304
    Abstract: The present invention relates to an immunoassay method for placental growth factor 2 (PlGF-2) detection in pregnant subjects. Furthermore the invention relates to the use of said method for the diagnosis, prognosis, risk assessment and therapy control of prenatal disorders comprising the determination of the level of PlGF-2 in said pregnant subjects.
    Type: Application
    Filed: December 3, 2014
    Publication date: January 5, 2017
    Applicant: CÉZANNE S.A.S.
    Inventors: Gaïané DEMIRDJIAN, Delphine ESPINASSE
  • MARKERS FOR THE PROGNOSIS AND RISK ASSESSMENT OF PREGNANCY-INDUCED HYPERTENSION AND PREECLAMPSIA
    Publication number: 20130177901
    Abstract: The present invention relates to the prognosis and risk assessment in pregnant women to develop pregnancy-induced hypertension and/or preeclampsia by the determination of marker levels.
    Type: Application
    Filed: June 17, 2011
    Publication date: July 11, 2013
    Applicant: CEZANNE S.A.S.
    Inventors: Bruno Darbouret, Gaiane Demirdjian